By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Eutilex 

Daeryung Technotown 17 Gasan digital 1-ro 25
Suite1401
Geumcheon-gu  Seoul   08594  Korea
Phone: 82-2-3402-7310 Fax: 82-2-3402-7399


SEARCH JOBS

Based in Seoul, South Korea, Eutilex is a clinical-stage biopharmaceutical company focused on the development of anti-tumor T cell and antibody therapeutics for the treatment of cancers and autoimmune diseases. The most advanced drug candidate is an adoptive T Cell therapy, which has finished Phase 1 clinical trials and will begin Phase 2. Other pipeline candidates in development include monoclonal antibodies, EU-101, EU-102 and EU-103.

LEADERSHIP:

Founder and CEO: Byoung S. Kwon

JOBS:

Please click here for Eutilex job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: partnering@eutilex.com
Ownership: Private

Web Site: Eutilex
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->